Neuroathletic Training in Adolescent Basketball Players
6. mai 2026 oppdatert av: Gizem Gül, Pamukkale University
Effects of Neuroathletic Training on Dynamic Visual Acuity, Endurance, Balance, Kinesiophobia, and Injury Risk in Adolescent Basketball Players: A Randomized Controlled Trial
This randomized controlled study aims to investigate the effects of neuroathletic training on dynamic visual acuity, endurance, balance, and injury risk in adolescent basketball players.
Licensed basketball players aged 14-17 years will be randomly assigned to either a neuroathletic training group or a control group.
The training group will receive sport-specific progressive neuroathletic exercises in addition to their regular basketball training for one week, while the control group will continue their usual training routine.
Before and after the intervention, participants will be assessed for dynamic visual acuity, core muscle endurance, balance, functional movement, pain, and kinesiophobia.
The findings of this study may help clarify whether neuroathletic training can improve performance-related outcomes and reduce injury risk in adolescent basketball players.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
30
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
Pamukkale/Kınıklı
-
Denizli, Pamukkale/Kınıklı, Tyrkia (Türkiye), 20070
- Pamukkale University
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
Aged between 14 and 17 years, Being a professional or amateur basketball player, Participating in sports for at least five hours per week and having engaged in the sport for a minimum of two years, Having no cognitive or motor dysfunction, Providing written informed consent signed by the parents/legal guardians.
Exclusion Criteria:
Reporting a back or lower extremity injury within the previous six months, Having any relevant medical history or current condition that could affect the balance system or perception-action system (e.g., neurological disorders, inner ear disorders, or color blindness), Using medications or substances that could affect balance and visual-motor reaction time performance.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Kontrollgruppe
|
|
|
Eksperimentell: Neuroatletisk Treningsgruppe
|
This intervention is a progressive neuroathletic training program developed by the research team to improve motor skills, balance, eye coordination, and vestibular function in adolescent basketball players.
The program is performed for approximately 20 minutes per day over 6 days and includes visual relaxation exercises, eye massage, unilateral vertical jumping, Brock string training, shoulder/wrist/ankle circular movements, sacculus activation, cerebellar activation, and antisaccade exercises.
The content is progressively advanced across days by integrating balance challenges and visual-vestibular tasks.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Functional Movement Screen (FMS) total score
Tidsramme: Baseline and immediately following the 1-week intervention
|
Assessment of injury risk and movement quality using the Functional Movement Screen total score.
The test consists of 7 movement patterns scored from 0 to 3, with higher scores indicating better functional movement quality and lower injury risk.
|
Baseline and immediately following the 1-week intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Dynamic Visual Acuity (DVA)
Tidsramme: Baseline and immediately following the 1-week intervention
|
Dynamic visual acuity assessed using a visual chart while the participant performs active horizontal head movements.
The lowest clearly read line will be recorded.
|
Baseline and immediately following the 1-week intervention
|
|
Balance Error Scoring System (BESS) / Denge Hata Puanlama Sistemi
Tidsramme: Baseline and immediately following the 1-week intervention
|
Postural stability assessed by the number of balance errors performed in double-leg, single-leg, and tandem stance conditions.
Lower scores indicate better balance performance.
|
Baseline and immediately following the 1-week intervention
|
|
Core muscle endurance (Prone plank test)
Tidsramme: Baseline and immediately following the 1-week intervention
|
Core endurance assessed by the duration the participant maintains the correct prone plank position.
Longer duration indicates better core endurance.
|
Baseline and immediately following the 1-week intervention
|
|
Tampa Scale for Kinesiophobia (TSK)
Tidsramme: Baseline and immediately following the 1-week intervention
|
Kinesiophobia assessed using the Tampa Scale for Kinesiophobia.
Higher scores indicate greater fear of movement.
|
Baseline and immediately following the 1-week intervention
|
|
Visual Analog Scale (VAS) for pain
Tidsramme: Baseline and immediately following the 1-week intervention
|
Pain intensity assessed using a 100-mm visual analog scale, with higher scores indicating greater pain intensity.
|
Baseline and immediately following the 1-week intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
15. februar 2025
Primær fullføring (Faktiske)
26. oktober 2025
Studiet fullført (Faktiske)
12. januar 2026
Datoer for studieregistrering
Først innsendt
29. april 2026
Først innsendt som oppfylte QC-kriteriene
6. mai 2026
Først lagt ut (Faktiske)
13. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
13. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
6. mai 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- PAU-FTR-GG-01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .